 | By Corporate Ads Renovaro, Inc. (N A S D A Q: RENB) $RENB Also Receives U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform
|
 | By Corporate Ads Innovative Designs (Stock Symbol: IVDN) $IVDN Super Small Share Structure with 38 Million OS / 17 Million Float and Record Sales Growth and Highest Profitability Level to Date for First 6 Months of 2025 With 265% Increase Year-Over-Year
|
 | By Corporate Ads $69 Million in Recent Contract Awards for Innovative, Disruptive Cybersecurity Leader Cycurion Inc. (N A S D A Q: CYCU) $CYCU; 2025 Q1 Gross Profit and Serves Some of the Most Complex Government Agencies Including Fortune 100 and 500 Companies
|
 | By Corporate Ads Cycurion, Inc. (N A S D A Q: CYCU): $CYCU is a High-Growth Cybersecurity Leader Riding the AI Wave.
|
 | By Corporate Ads VSee Health (N A S D A Q: VSEE) $VSEE Major Clients Include NASA, U.S. Department of Health and Human Services, McKesson, DaVita and the Entire Nation of Qatar
|
 | By Corporate Ads IQSTEL Inc. (N A S D A Q: IQST) $IQST Driven by strong organic growth, high-margin expansion, and strategic acquisitions, IQST now forecasts hitting a $400 million annualized revenue run rate by year-end, as it races toward its $1 billion revenue goal by.
|
 | By Corporate Ads (N A S D A Q: AMOD) $AMOD with Major IP Lawsuits, Strategic Partnerships, and a $3M CEO Investment, Alpha Modus Is Emerging as a Powerhouse in AI-Driven Retail Infrastructure
|
 | By Corporate Ads NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP Has $7.8 Million for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute as Treatment Model and Leading Investigative Site for Suicidal Depression / PTSD
|
By The Stalking Butler LLC Follow. Learn. Earn. Follow your favorite hedge funds and portfolio managers and learn how to invest.
|
 | By Corporate Ads Cycurion, Inc. (N A S D A Q: CYCU) and IQSTEL, Inc. (N A S D A Q: IQST) are leading the AI Telecom and Cybersecurity Charge.
|
By STS Capital Partners STS Capital Partners is pleased to announce the appointment of Mauro Schnaidman as a Managing Director, based in Miami, Florida.
|
 | By CorporateAds Bullet Blockchain, Inc. (Stock Symbol: BULT) $BULT Controls Ownership of Intellectual Property Portfolio That Includes Two Key Bitcoin & Crypto ATM Patents
|
 | By Corporate Ads Cycurion (N A S D A Q: CYCU) $CYCU Cycurion, Inc. Serves Some of the Most Complex Government Agencies and Corporations, Including Fortune 100 and 500 Companies
|
 | By Corporate Ads Cycurion, Inc. (N A S D A Q: CYCU) $CYCU Reports 2025 Q1 Gross Profit of $677,673, Up 95.4% Year-Over-Year, with 17.5% Gross Margin Increase
|
 | By Corporate Ads IQSTEL, Inc. (Stock Symbol: IQST) $IQST Current Plans Include $1 Million Subsidiary Sale with Stock Dividend to Shareholders
|
 | By Corporate Ads NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Has $7.8 Million in Financing for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute as Treatment Model and Leading Investigative Site for Suicidal Depression / PTSD
|
 | By FOLIUM FINANCIAL LIMITED Remember when Robinhood first went online? The slogan of "zero commission trading" immediately attracted a large number of young investors, and almost overnight, U.S. stock investment was brought into everyone's mobile phone.
|
 | By Corporate Ads IQSTEL, Inc. (Stock Symbol: IQST) $IQST Also Moves Forward on $1 Million Subsidiary Sale with Stock Dividend to Shareholders
|
 | By ExpertOps AI Digital employees that autonomously run operations, support teams, and engage customers intelligently — at 10x efficiency.
|
 | By Corporate Ads $IVDN Innovative Designs, Inc. (Stock Symbol: IVDN) Board Member has Ties to Industry Leaders Including D.R. Horton $DHI, Ryan Homes $NVR and More / Super Small Share Structure with Only 38 Million OS / 16 Million Float
|
 | By Corporate Ads $NRXP Closing $7.8 Million in Financing for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute Treatment Model and Leading Investigative Site
|
 | By Corporate Ads $IQST IQSTEL, Inc. (Stock Symbol: IQST) Forecasts $340 Million Revenue for 2025.
|
 | By Corporate Ads $NRXP NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP): Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties
|
 | By Corporate Ads $CYCU Cycurion, Inc. (Stock Symbol: CYCU) Has Delivered $17.8 Million Revenue with +59% y/y Adjusted EBITDA Generating $1.2 Million Net Income for 2024 Full Year.
|
 | By Corporate Ads NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties
|
 | By Corporate Ads Cadrenal Therapeutics, Inc. (Stock Symbol: CVKD) $CVKD Tecarfarin Anticoagulant Reduces Drug on Drug Interactions Which Pose a Major Issue with Warfarin. Successful Phase III Could Enhance Liquidity and Quickly Attract Large Institutional Investors.
|
 | By Corporate Ads Cybersecurity stocks to watch: $cycu $panw $zs $crwd $chkp $cybr $ftnt $okta $net $ffiv
|
 | By Corporate Ads IQSTEL, Inc. (Stock Symbol: IQSTD) On Track Towards $1 Billion in Revenue by 2027.
|
By STS Capital Partners STS Capital Partners is pleased to announce the appointment of Jay Tapp as a Managing Director, based in British Columbia, Canada.
|
 | By Corporate Ads $BEAT Clinical Endpoints Successfully Met in Pivotal Study, Plus FDA Clearance for At-Home, High-Fidelity Heart Monitoring System.
|
 | By CorporateAds $IQSTD Also Signs MOU to Acquire Majority Stake in Fintech Leader GlobeTopper, Plus $1 Million Subsidiary Sale with Stock Dividend to Shareholders. iQSTEL, Inc. (Stock Symbol: IQSTD)
|